Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

CTSH-AI-NVIDIA

More Like This

PR Newswire associated0

Cognizant to Deploy Neuro AI Platform to Accelerate Enterprise AI Adoption in Collaboration with NVIDIA

PR Newswire associated0

Cognizant Unveils Advanced Artificial Intelligence Lab to Accelerate AI Research and Innovation

PR Newswire associated0

Announcing Cognizant Flowsource™, a generative AI-enabled platform for powering modern engineering

PR Newswire associated0

Cognizant Announces Multi-Agent Orchestration for its Neuro® AI Platform

PR Newswire associated0

Cognizant unveils gen AI-powered Innovation Assistant, in collaboration with Microsoft, empowering Cognizant's employees to innovate

PR Newswire associated0

Cognizant and Google Cloud Expand AI Partnership to Drive Software Development Productivity

PR Newswire associated0

Infosys and NVIDIA Collaborate to Help World's Enterprises Boost Productivity with Generative AI

Image of the ReSync platform showing the integrated output of a partner model from NVIDIA.

ReSync Bio to Democratize AI-Powered Drug Discovery with NVIDIA BioNeMo